Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Other Non-Current Liabilities (2019 - 2025)

Historic Other Non-Current Liabilities for AVITA Medical (RCEL) over the last 6 years, with Q4 2025 value amounting to $1.2 million.

  • AVITA Medical's Other Non-Current Liabilities fell 6378.21% to $1.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 million, marking a year-over-year decrease of 6378.21%. This contributed to the annual value of $1.2 million for FY2025, which is 6378.21% down from last year.
  • Per AVITA Medical's latest filing, its Other Non-Current Liabilities stood at $1.2 million for Q4 2025, which was down 6378.21% from $1.9 million recorded in Q3 2025.
  • Over the past 5 years, AVITA Medical's Other Non-Current Liabilities peaked at $4.0 million during Q1 2024, and registered a low of $19000.0 during Q1 2021.
  • Over the past 5 years, AVITA Medical's median Other Non-Current Liabilities value was $1.6 million (recorded in 2022), while the average stood at $1.7 million.
  • In the last 5 years, AVITA Medical's Other Non-Current Liabilities soared by 290526.32% in 2022 and then plummeted by 6378.21% in 2025.
  • Over the past 5 years, AVITA Medical's Other Non-Current Liabilities (Quarter) stood at $113000.0 in 2021, then soared by 1092.92% to $1.3 million in 2022, then surged by 134.27% to $3.2 million in 2023, then rose by 8.68% to $3.4 million in 2024, then tumbled by 63.78% to $1.2 million in 2025.
  • Its Other Non-Current Liabilities stands at $1.2 million for Q4 2025, versus $1.9 million for Q3 2025 and $1.9 million for Q2 2025.